Sysmex Inostics’ Liquid Biopsy Testing Aids Pancreatic Cancer Management
cfDNA-based liquid biopsy analysis of KRAS mutations using OncoBEAM technology can assist in the prognosis determination and management of PDAC patients.
Read MorePosted by Melanie Hamilton-Basich | Sep 9, 2020 | Molecular Diagnostics, Pancreatic |
cfDNA-based liquid biopsy analysis of KRAS mutations using OncoBEAM technology can assist in the prognosis determination and management of PDAC patients.
Read MorePosted by | May 6, 2020 | Cancer, Pancreatic |
Penn study shows liquid biopsy may be viable option for both diagnosis and disease staging of pancreatic cancer.
Read MorePosted by Steve Halasey | Sep 28, 2018 | Pancreatic |
Immunovia’s serum biomarker microarray detects pancreatic cancer in the early stages of development with 96% accuracy.
Read MorePosted by Elaine Sanchez Wilson | Feb 9, 2016 | Cancer, Microbiology Instruments, Molecular Diagnostics |
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Read MorePosted by Elaine Sanchez Wilson | Oct 14, 2015 | Fertility Testing, Pancreatic, Uncategorized |
This month’s Product News features an LED illuminator from Excelitas Technologies, a pancreatic cancer test from Interpace Diagnostics, and an integrated hardware and software system from Carl Zeiss Microscopy.
Read More